Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acquired haemophilia caused by non-haemophilic factor VIII gene variants.

Annals of hematology - 1 Jun 2010

Tiede Andreas, Eisert Roswith, Czwalinna Andreas, Miesbach Wolfgang, Scharrer Inge, Ganser Arnold

Abstract excerpt

The aetiology of anti-factor VIII (FVIII) autoantibody formation in acquired haemophilia remains unknown. We hypothesised that encounter of antigenically different, allogeneic FVIII may challenge inhibitor formation after presentation on MHC class II. Eighteen consecutive cases with acquired haem...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Blood Coagulation Factor Inhibitors
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor VIII

Share to Hemophilia A

Share to HLA-DR Antigens

Share to HLA-DRB1 Chains

Share to Young Adult

Source

Identifiers

PMID: 20054547
DOI: 10.1007/s00277-009-0887-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20054547-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acquired haemophilia caused by non-haemophilic factor VIII gene variants.PMID 20054547Read ↗

FVIII Immunogenicity-Bioinformatic Approaches to Evaluate Inhibitor Risk in Non-severe Hemophilia A.Semantic proximity Read ↗

<i>In silico</i> calculated affinity of FVIII‐derived peptides for <scp>HLA</scp> class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 geneSemantic proximity Read ↗

Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement.Semantic proximity Read ↗

A large-scale computational study of inhibitor risk in non-severe haemophilia A.Semantic proximity Read ↗

Key insights to understand the immunogenicity of FVIII products.Semantic proximity Read ↗

Haemophilia management: time to get personal?Semantic proximity Read ↗

Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B.Semantic proximity Read ↗

Risk factors for inhibitor development in hemophilia A.Semantic proximity Read ↗

Environmental and genetic factors influencing inhibitor development.Semantic proximity Read ↗

Clinical heterogeneity of acquired hemophilia A: a description of 4 cases.Semantic proximity Read ↗

Correlation between factor VIII genotype and inhibitor development in hemophilia A.Semantic proximity Read ↗

Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.